Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of IPI-145 in Combination with Rituximab vs Rituximab in Subjects with Previously-Treated Follicular Lymphoma

  • Pan, Dorothy (PI)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date12/12/14 → 12/11/16

Funding

  • Infinity Pharmaceuticals Incorporated: $9,562.50